A detailed history of Prosight Management, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 705,109 shares of KURA stock, worth $6.25 Million. This represents 3.7% of its overall portfolio holdings.

Number of Shares
705,109
Previous 629,900 11.94%
Holding current value
$6.25 Million
Previous $13 Million 6.23%
% of portfolio
3.7%
Previous 4.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.57 - $23.23 $1.4 Million - $1.75 Million
75,209 Added 11.94%
705,109 $13.8 Million
Q2 2024

Aug 14, 2024

SELL
$17.53 - $22.98 $5.79 Million - $7.59 Million
-330,100 Reduced 34.39%
629,900 $13 Million
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $134,200 - $235,300
10,000 Added 1.05%
960,000 $20.5 Million
Q4 2023

Feb 14, 2024

SELL
$7.58 - $14.38 $7.45 Million - $14.1 Million
-982,456 Reduced 50.84%
950,000 $13.7 Million
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $4.97 Million - $6.99 Million
589,097 Added 43.85%
1,932,456 $17.6 Million
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $12.9 Million - $18.8 Million
1,343,359 New
1,343,359 $14.2 Million
Q4 2020

Feb 12, 2021

SELL
$29.0 - $41.62 $3.11 Million - $4.47 Million
-107,367 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$16.3 - $30.64 $9.42 Million - $17.7 Million
-577,633 Reduced 84.33%
107,367 $3.29 Million
Q2 2020

Aug 14, 2020

SELL
$7.95 - $18.81 $6.08 Million - $14.4 Million
-765,000 Reduced 52.76%
685,000 $11.2 Million
Q1 2020

May 15, 2020

BUY
$6.45 - $14.04 $2.67 Million - $5.81 Million
414,000 Added 39.96%
1,450,000 $14.4 Million
Q4 2019

Feb 14, 2020

BUY
$12.97 - $15.94 $1.92 Million - $2.36 Million
147,848 Added 16.65%
1,036,000 $14.2 Million
Q3 2019

Nov 14, 2019

BUY
$14.75 - $20.87 $300,044 - $424,537
20,342 Added 2.34%
888,152 $13.5 Million
Q2 2019

Aug 14, 2019

BUY
$14.71 - $19.79 $10.2 Million - $13.8 Million
694,916 Added 401.93%
867,810 $17.1 Million
Q1 2019

May 15, 2019

SELL
$13.73 - $16.87 $1.97 Million - $2.42 Million
-143,687 Reduced 45.39%
172,894 $2.87 Million
Q4 2018

Feb 14, 2019

BUY
$10.6 - $17.49 $667,270 - $1.1 Million
62,950 Added 24.82%
316,581 $4.45 Million
Q3 2018

Nov 15, 2018

SELL
$16.65 - $21.85 $570,362 - $748,493
-34,256 Reduced 11.9%
253,631 $4.44 Million
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $4.26 Million - $5.41 Million
287,887 New
287,887 $5.24 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $593M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.